ViroReal® MERS-CoV


ViroReal MERS-CoV_RTGVViroReal Assay VIC VET RNA mit Gefahrensymbol



Background: Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is a beta coronavirus causing Middle East Respiratory Syndrome (MERS), a zoonotic and severe respiratory disease in humans. To date, MERS-CoV has only been isolated from dromedary camels and humans. In humans, it was first identified in April 2012. Camels are a likely primary source of the MERS-CoV infection in humans.

ViroReal® MERS-CoV is a detection assay for rapid and sensitive detection of RNA of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) by reverse transcription real-time PCR.

Specificity and sensitivity: See product description

Also available as kitversion: ViroReal® Kit MERS-CoV

Product ViroReal® MERS-CoV
Order no. RTGV31
Unit 100 reactions
Technology Reverse transcription real-time PCR
Target gene Nucleocapsid (N) , detection in VIC/HEX channel
Content Assay (pimers + probe) for MERS-CoV
Positive Control MERS-CoV
Amplification mix & IPC Not included, see product description
PCR-Platforms Evaluated for ABI PRISM® 7500, LightCycler® 480 and MX3005P. Assay can also be used with other real-time PCR instruments.


Internal Positive Control (IPC) ÔÇô not included, optional: For control of RNA extraction and exclusion of false-negative interpretation of results caused by inhibition of reverse transcription and real-time PCR an ingenetix Internal Positive RNA Control Assay can be optionally performed in a multiplex PCR, depending on the PCR-platform. Internal Positive RNA Control Assays (order no. RTGMIPCR1, 2 or 3) contain primers, a probe and an internal control RNA target in an extra tube. See product description.

ViroReal® Assays detecting viral RNA are optimized to run under the same thermal cycling conditions and with the same amplification mix.